Venetoclax and Ibrutinib in Treating Patients With Chronic or Small Lymphocytic Leukemia

Clinical trial NCT02756897 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02756897
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia Recurrent Chronic Lymphocytic Leukemia Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Small Lymphocytic Lymphoma Small Lymphocytic Lymphoma

Start date: 2016-07-07
Primary completion: 2027-07-01
Enrollment: 234

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.